Amy Apostoleris retweetledi
Amy Apostoleris
77 posts

Amy Apostoleris
@AmyApostoleris
Strategic Development Leader collaborating with organizations to develop and drive innovative solutions and business strategies within Healthcare and Pharma
Katılım Mart 2021
38 Takip Edilen10 Takipçiler
Amy Apostoleris retweetledi
Amy Apostoleris retweetledi

Congratulations to the recipients of the 2023 Route 79 Scholarships! Now in its 6th year, the program provides academic scholarships to those living with #Duchenne and siblings in Duchenne families to support post-secondary educational goals. Read more: bit.ly/3Z7Esod
English
Amy Apostoleris retweetledi

@MedocityInc’s proprietary REACH™️ solution recruits and qualifies patients for LSO PSPs, including those of specified race, culture, demographics and SDOH to help remove barriers to participation. To learn more, contact @Loreenmmarshall.
#patientsfirst #techquity #REACHplatform

English
Amy Apostoleris retweetledi

Nonadherence, per the @NIH, is often due to #forgetfulness, #illiteracy & #lackoftrust.
To learn how @Medocity’s digital patient support solutions provide a #personalized, interactive experience throughout the #carejourney while improving #outcomes, contact @Loreenmmarshall.

English
Amy Apostoleris retweetledi

@MedocityInc is solving key challenges for gene therapy clinical trials. Our innovative digital solutions improve the quality of patient candidates, decrease screening fail rates, reduce study timelines, and enhance site relationships. Contact @AmyApostoleris to schedule a demo.

English
Amy Apostoleris retweetledi

Today's successful PSP are tailored, dynamic, streamlined, interoperable & holistic.
@MedocityInc's digital solutions meet these criteria with personalized, evolving, seamless care journeys that connect, support & engage patients in real-time. DM @loreenmmarshall to learn more.

English
Amy Apostoleris retweetledi

In a rare disease clinical program, @MedocityInc’s REACH™ Platform increased patient identification & decreased enrollment timelines across all trials.
Learn more about REACH & this case study at bit.ly/3jYVEwj or by contacting @AmyApostoleris.
#REACHPlatform #DCT

English
Amy Apostoleris retweetledi
Amy Apostoleris retweetledi

💡Check out our latest blog about the need for LSOs to continuously adapt & evolve with changes in regulations, technology, & patient needs, while staying focused on nurturing authentic care & building strategic teams: bit.ly/406MrkA
#patientsfirst #digitalpatientsupport
English
Amy Apostoleris retweetledi

Last month, @MedocityInc’s @loreenmmarshall presented “Cell & Gene Therapies: Creating A Digital Ecosystem Strategy to Ensure a Smooth Patient Journey"
bit.ly/3MFgBbB
Listen in to learn how to create patient-centric, digital butterflies for cell & gene therapies. 📱🦋
English
Amy Apostoleris retweetledi

Understanding trust is key to clinical trial recruitment & enrollment success, @MedocityInc developed REACH™️, a patient recruitment, eligibility, & enrollment solution that accelerates timelines, reduces dropouts, & improves retention.
Contact @AmyApostoleris to learn more.

English
Amy Apostoleris retweetledi

🌴😎📱 @MedocityInc is excited to be attending #OCTWestCoast this year!
Stop by Booth #34 today to meet @karenkeeley14 & learn more about #Medocity’s REACH™️ Platform, which improves #recruitment & #enrollment in rare disease studies.
#patientsfirst #REACHPlatform

English
Amy Apostoleris retweetledi

Are you having challenges with your #recruitment and #enrollment efforts for #raredisease studies?
Connect with @KarenKeeley14 next week at the #OCTWestCoast conference to discuss how our REACH™️ solution can help you meet or exceed your enrollment goals.
#patientsfirst

English
Amy Apostoleris retweetledi

@MedocityInc's #REACHplatform ingests #RWD data from 50B claim transactions, 350M lives & 2.3M HCPs to provide a heterogeneous view of patients, providers & outcomes to increase recruitment & accelerate timelines.
To learn more, contact @AmyApostoleris.
English
Amy Apostoleris retweetledi

🤔🔦💡ICYMII....
@Fishawack's C> report stressed pharma should increase focus on areas such as #healthequity, #patientfocused #drugdevelopment, & #clinicaltrialdiversity.
For more on @MedocityInc’s digital C> solutions, contact @loreenmmarshall.
bit.ly/3P3pUAX
English
Amy Apostoleris retweetledi

November is #LungCancerAwarenessMonth.
Join @MedocityInc working to increase awareness about preventative screenings and the symptoms of this deadly disease. Your life or the life of someone you love may depend upon it.
#lungcancerawareness #preventativescreening #digitalcare

English




